Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Uveal Melanoma × entinostat × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1

Interventions

Melphalan 3 Interleukin-2 3 Nivolumab 2 Ipilimumab 2 pembrolizumab 1 entinostat 1 Tramadol 1 Ibuprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02697630 2023-12-08

PEMDAC

Vastra Gotaland Region

Phase 2 Completed

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡